Successful treatment of hepatosplenic T-cell lymphoma with fludarabine, high-dose cytarabine and subsequent unrelated umbilical cord blood transplantation-Reference-Cited by-同舟云学术

Successful treatment of hepatosplenic T-cell lymphoma with fludarabine, high-dose cytarabine and subsequent unrelated umbilical cord blood transplantation

Published:2021-09-30 Issue:1 Volume:115 Page:140-145
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Honda Takaya,Yamaoka Masayoshi,Terao Yoko Mikami,Hasegawa Daisuke,Kumamoto Tadashi,Takagi Masatoshi,Yoshida Kenichi,Ogawa Seishi,Goto Hiroaki,Akiyama Masaharu^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

https://link.springer.com/content/pdf/10.1007/s12185-021-03229-0.pdf

Reference30 articles.

1. Ferrei AJM, Govi S, Pileri SA. Hepatosplenic gamma-delta T-cell lymphoma. Crit Rev Oncol Hematol. 2012;83:283–92.

2. Lu C, Tang Y, Yang Q, Wang M, Zhao S, Bi C, et al. Hepatosplenic T-cell lymphoma: clinicopathologic, immunophenotypic, and molecular characterization of 17 Chinese cases. Human Pathol. 2011;42:1965–78.

3. Domm JA, Thompson M, Kuttesch JF, Acra S, Frangoul H. Allogenic bone marrow transplantation for chemotherapy-refractory hepatosplenic γδ T-cell lymphoma. J Pediatr Hematol Oncol. 2005;27:607–10.

4. Takahashi H, Kajiwara R, Kato M, Hasegawa D, Tomizawa D, Nogichi Y, et al. Treatment outcome of children with acute lymphoblastic leukemia: the Tokyo Children’s Cancer Study Group (TCCSG) study L04-16. Int J Hematol. 2018;108:98–108.

5. Estey E, Thall P, Andreeff M, Beran M, Kantarjian H, O’Brien S, et al. Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factor. J Clin Oncol. 1994;12:671–8.